Campbell David Alan
SEC insider (Form 3/4/5 filer). CIK 0001864158. President and CEO at Janux Therapeutics, Inc. (JANX). 15 reported Form 4/5 transactions since Sep 2024; latest on Jul 31, 2026. Located in SAN DIEGO, CA.
Companies Campbell David Alan has filed insider reports for
- Janux Therapeutics, Inc. (JANX): Director, Officer, President and CEO
Campbell David Alan
CIK: 0001864158
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Janux Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jul 31, 2026JANX
Janux Therapeutics, Inc.
GiftDirect123.8K shares- - Jul 8, 2026JANX
Janux Therapeutics, Inc.
ExerciseDirect7K shares at avg. $4.21$29K - Jan 2, 2026JANX
Janux Therapeutics, Inc.
AwardDirect96.6K shares- - Jan 2, 2026JANX
Janux Therapeutics, Inc.
SaleDirect8.1K shares at avg. $13.73$111K - Jan 7, 2025JANX
Janux Therapeutics, Inc.
SaleDirect5K shares at avg. $60.00$300K - Jan 2, 2025JANX
Janux Therapeutics, Inc.
AwardDirect81K shares- - Dec 24, 2024JANX
Janux Therapeutics, Inc.
SaleDirect25K shares at avg. $56.19$1.4M - Dec 3, 2024JANX
Janux Therapeutics, Inc.
SaleDirect15K shares at avg. $67.00$1.0M - Nov 25, 2024JANX
Janux Therapeutics, Inc.
SaleDirect18.3K shares at avg. $51.43$940K - Nov 25, 2024JANX
Janux Therapeutics, Inc.
SaleDirect6.7K shares at avg. $52.04$350K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2026 | JANX Janux Therapeutics, Inc. | Gift | 123,840 | - | $0 | Direct |
| Jul 8, 2026 | JANX Janux Therapeutics, Inc. | Exercise | 7,000 | $4.21 | $29,470 | Direct |
| Jan 2, 2026 | JANX Janux Therapeutics, Inc. | Award | 96,600 | - | $0 | Direct |
| Jan 2, 2026 | JANX Janux Therapeutics, Inc. | Sale | 8,072 | $13.73 | $110,829 | Direct |
| Jan 7, 2025 | JANX Janux Therapeutics, Inc. | Sale | 5,000 | $60.00 | $300,004 | Direct |
| Jan 2, 2025 | JANX Janux Therapeutics, Inc. | Award | 81,000 | - | $0 | Direct |
| Dec 24, 2024 | JANX Janux Therapeutics, Inc. | Sale | 25,000 | $56.19 | $1,404,805 | Direct |
| Dec 3, 2024 | JANX Janux Therapeutics, Inc. | Sale | 15,000 | $67.00 | $1,005,000 | Direct |
| Nov 25, 2024 | JANX Janux Therapeutics, Inc. | Sale | 18,281 | $51.43 | $940,232 | Direct |
| Nov 25, 2024 | JANX Janux Therapeutics, Inc. | Sale | 6,719 | $52.04 | $349,647 | Direct |
1-10 of 15 transactions